Anxiety and cardiovascular disease

Modern Trends in Pharmacopsychiatry

Volumn 29, Issue , 2013, Pages 85-97

  Davies, Simon J C ^a,b   Allgulander, Christer ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANXIETY; ANXIETY DISORDER; ARTICLE; AUTONOMIC NEUROPATHY; BEHAVIOR; CARDIOVASCULAR DISEASE; DEPRESSION; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; PANIC; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; THROMBOCYTE DYSFUNCTION; ANIMAL; REVIEW;

ANIMALS; ANXIETY; CARDIOVASCULAR DISEASES; HUMANS;

EID: 84908027061     PISSN: 16622685     EISSN: 16624505     Source Type: Book Series    
DOI: 10.1159/000351945     Document Type: Article

References (74)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913
2. White GW: The New Hampshire Academy of Science. Science 1931; 74: 98
3. Mancia G, Grassi G, Parati G, Zanchetti A: The sympathetic nervous system in human hypertension. Acta Physiol Scand Suppl 1997; 640: 117-121
4. Esler M: The sympathetic system and hypertension. Am J Hypertens 2000; 13: 99S-105S
5. White WB, Baker LH: Episodic hypertension secondary to panic disorder. Arch Int Med 1986; 146: 1129-1130
6. Weissman MM, Markowitz JS, Ouellette R, Greenwald S, Kahn JP: Panic disorder and cardiovascular/ cerebrovascular problems: results from a community survey. Am J Psychiatry 1990; 147: 1504-1508
7. Davies SJC, Ghahramani P, Jackson PR, Noble TW, Hardy P, Hippisley-Cox J, Yeo WW, Ramsay LE: Association of panic disorder and panic attacks with hypertension. Am J Med 1999; 107: 310-316
8. Grimsrud A, Stein DJ, Seedat S, Williams D, Myer L: The association between hypertension and depression and anxiety disorders: results from a nationallyrepresentative sample of South African adults. PLoS One 2009; 4:e5552
9. Jonas BS, Franks P, Ingram DD: Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med 1997; 6: 43-49
10. Paterniti S, Alperovitch A, Ducimetiere P, Dealberto MJ, Lepine JP, Bisserbe JC: Anxiety but not depression is associated with elevated blood pressure in a community group of French elderly. Psychosom Med 1999; 61: 77-83
11. Shinn EH, Poston WS, Kimball KT, St Jeor ST, Foreyt JP: Blood pressure and symptoms of depression and anxiety a prospective study. Am J Hypertens 2001; 14: 660-664
12. Sparrow D, Garvey AJ, Rosner B, Thomas HE Jr: Factors in predicting blood pressure change. Circulation 1982; 65: 789-794
13. Pilgrim JA, Stansfeld S, Marmot M: Low blood pressure, low mood? BMJ 1992; 304: 75-78
14. Hildrum B, Mykletun A, Stordal E, Bjelland I, Dahl AA, Holmen J: Association of low blood pressure with anxiety and depression: the Nord-Trondelag Health Study. J Epidemiol Community Health 2007; 61: 53-58
15. Pemberton J: Does constitutional hypotension exist? BMJ 1989; 298: 660-662
16. Davies SJC, Bjerkeset O, Nutt DJ, Lewis G: A Ushaped relationship between systolic blood pressure and panic symptoms: the HUNT study. Psychol Med 2012; 17: 1-8
17. Davies SJC, Jackson PR, Lewis G, Hood SD, Nutt DJ, Potokar JP: Is the association of hypertension and panic disorder explained by the clustering of autonomic panic symptoms in hypertensive patients? J Affect Disord 2008; 111: 344-350
18. Mann SJ: Neurogenic essential hypertension revisited: the case for increased clinical and research attention. Am J Hypertens 2003; 16: 881-888
19. Esler M, Rumantir M, Kaye D, Jennings G, Hastings J, Socratous F, et al: Sympathetic nerve biology in essential hypertension. Clin Exp Pharmacol Physiol 2001; 28: 986-989
20. Wilkinson DJ, Thompson JM, Lambert GW, Jennings GL, Schwarz RG, Jefferys D, et al: Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry 1998; 55: 511-520
21. Nutt DJ: Altered central alpha 2-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 1989; 46: 165-169
22. Ferrier C, Cox H, Esler M: Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci (Lond) 1993; 84: 225-230
23. Bell C, Forshall S, Adrover M, Nash J, Hood S, Argyropoulos S, et al: Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. J Psychopharmacol (Oxf) 2002; 16: 5-14
24. Polyák J: How should we manage cardiovascular panic disorder accompanied by hypertension? J Hypertens 2001; 19:S64
25. Yeragani VK, Sobolewski E, Igel G, Johnson C, Jampala VC, Kay J, et al: Decreased heart-period variability in patients with panic disorder: A study of Holter ECG records. Psychiatry Res 1998; 20; 78: 89-99
26. Friedman BH, Thayer JF: Autonomic balance revisited: panic anxiety and heart rate variability. J Psychosom Res 1998; 44: 133-151
27. Yeragani VK, Jampala VC, Sobelewski E, Kay J, Igel G: Effects of paroxetine on heart period variability in patients with panic disorder: A study of holter ECG records. Neuropsychobiology 1999; 40: 124-128
28. Davies SJ, Hood SD, Argyropoulos SV, Morris K, Bell C, Witchel HJ, et al: Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders. J Clin Psychopharmacol 2006; 26: 414-418
29. Davies SJ, Lowry CA, Nutt DJ: Panic and hypertension: brothers in arms through 5-HT? J Psychopharmacol 2007; 21: 563-566
30. Weizman R, Laor N, Wiener Z, Wolmer L, Bessler H: Cytokine production in panic disorder patients. Clin Neuropharmacol 1999; 22: 107-109
31. Norman TR, Judd FK, Gregory M, James RH, Kimber NM, McIntyre IM, et al: Platelet serotonin uptake in panic disorder. J Affect Disord 1986; 11: 69-72
32. Kaplan NM: Anxiety-induced hyperventilation: A common cause of symptoms in patients with hypertension. Arch Intern Med 1997; 157: 945-948
33. Klein DF: False suffocation alarms, spontaneous panics, and related conditions. Arch Gen Psychiatry 1993,50: 306-317
34. Davies SJC, Jackson PR, Ramsay LE, Ghahramani P: Drug intolerance due to non-specific side effects related to psychiatric morbidity in hypertensive patients. Arch Intern Med 2003; 163: 592-600
35. Pickering TG, Devereux RB, Gerin W, James GD, Pieper C, Schlussel YR, et al: The role of behavioral factors in white coat and sustained hypertension. J Hypertens Suppl 1990; 8:S141-S147
36. Davies SJ, Jackson PR, Ramsay LE, Ghahramani P, Palmer RL, Hippisley-Cox J: No evidence that panic attacks are associated with the white coat effect in hypertension. J Clin Hypertens (Greenwich) 2003; 5: 145-152
37. Macdonald LA, Sackett DL, Haynes RB, Taylor DW: Labelling in hypertension: A review of the behavioural and psychological consequences. J Chronic Dis 1984; 37: 933-942
38. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A: Depression and the risk for cardiovascular diseases: systematic review and meta-analysis. Int J Geriatr Psychiatry 2007; 22: 613-626
39. Frasure-Smith N, Lespérance F: Recent evidence linking coronary heart disease and depression. Can J Psychiatry 2006; 51: 730-737
40. Stamfer HG, Hince DA, Dimmett SB: Depression as a risk factor for coronary heart disease-How strong is the evidence? Open J Psychiatry 2012; 2: 284-291
41. Roest AM, Martens EJ, de Jone P, et al: Anxiety and risk of incident coronary heart disease: A meta-analysis. J Am Coll Cardiol 2010; 56: 38-46
42. Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, et al: Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry 2007; 64: 1153-1160
43. Gomez-Caminero A, Blumentals WA, Russo LJ, Brown RR, Castilla-Puentes R: Does panic disorder increase the risk of coronary heart disease? A cohort study of a national managed care database. Psychosom Med 2005; 67: 688-691
44. Chen YH, Tsai SY, Lee HC, Lin HC: Increased risk of acute myocardial infarction for patients with panic disorder: A nationwide population-based study. Psychosom Med 2009; 71: 798-804
45. Walters K, Rait G, Petersen I, Williams R, Nazareth I: Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database. Eur Heart J 2008; 29: 2981-2988
46. Janszky I, Ahnve S, Lundberg I, et al: Early-onset depression, anxiety and risk of subsequent coronary heart disease. 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol 2010; 56: 31-37
47. Coryell W, Noyes R, Clancy J: Excess mortality in panic disorder: A comparison with primary unipolar depression. Arch Gen Psychiatry 1982; 39: 701-703
48. Coryell W, Noyes R Jr, House JD: Mortality among outpatients with anxiety disorders. Am J Psychiatry 1986; 143: 508-510
49. Crown S, Crisp AH: A short clinical diagnostic selfrating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry 1966; 112: 917-923
50. Haines AP, Imeson JD, Meade TW: Phobic anxiety and ischaemic heart disease. BMJ (Clin Res Ed) 1987; 295: 297-299
51. Kawachi I, Sparrow D, Vokonas PS, Weiss ST: Symptoms of anxiety and risk of coronary heart disease: the Normative Aging Study. Circulation 1994; 90: 2225-2229
52. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I: Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005; 111: 480-487
53. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, et al: Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89: 1992-1997
54. Watkins LL, Blumenthal JA, Davidson JR, Babyak MA, McCants CB Jr, Sketch MH Jr: Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med 2006; 68: 651-656
55. Fleet RP, Beitman BD: Cardiovascular death from panic disorder and panic-like anxiety: A critical review of the literature. J Psychosom Res 1998; 44: 71-80
56. Suls J, Bunde J: Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull 2005; 131: 260-300
57. Parker G, Hyett M, Hadzi-Pavlovic D, Brotchie H, Walsh W: GAD is good? Generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome. Psychiatry Res 2011; 188: 383-389
58. Kleiger RE, Miller JP, Bigger JT Jr, et al: Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-262
59. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, et al: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709
60. Rasmussen A, Lunde M, Poulsen DL, Sørensen K, Qvitzau S, Bech P: A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003; 44: 216-221
61. Lehnert H, Lombardi F, Raeder EA, Lorenzo AV, Verrier RL, Lown B, et al: Increased release of brain serotonin reduces vulnerability to ventricular fibrillation in the cat. J Cardiovasc Pharmacol 1987; 10: 389-397
62. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA: Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279-1283
63. Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C: Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis 2006; 185: 320-326
64. von Känel R, Kudielka BM, Metzenthin P, Helfricht S, Preckel D, Haeberli A, Stutz M, Fischer JE: Aspirin, but not propranolol, attenuates the acute stress-induced increase in circulating levels of interleukin-6: A randomized, double-blind, placebo-controlled study. Brain Behav Immun 2008; 22: 150-157
65. Yamakawa K, Matsunaga M, Isowa T, Kimura K, Kasugai K, Yoneda M, Kaneko H, Ohira H: Transient responses of inflammatory cytokines in acute stress. Biol Psychol 2009; 82: 25-32
66. Wirtz PH, Ehlert U, Emini L, Suter T: Higher body mass index (BMI) is associated with reduced glucocorticoid inhibition of inflammatory cytokine production following acute psychosocial stress in men. Psychoneuroendocrinology 2008; 33: 1102-1110
67. Brydon L, Walker C, Wawrzyniak A, Whitehead D, Okamura H, Yajima J, Tsuda A, Steptoe A: Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav Immun 2009; 23: 217-224
68. Dell'Osso L, Carmassi C, Palego L, Trincavelli ML, Tuscano D, Montali M, et al: Serotonin-mediated cyclic AMP inhibitory pathway in platelets of patients affected by panic disorder. Neuropsychobiology 2004; 50: 28-36
69. Marcourakis T, Gorenstein C, Brandao de Almeida PE, Ramos RT, Glezer I, Bernardes CS, et al: Panic disorder patients have reduced cyclic AMP in platelets. J Psychiatr Res 2002; 36: 105-110
70. Tardito D, Zanardi R, Racagni G, Manzoni T, Perez J: The protein kinase A in platelets from patients with panic disorder. Eur Neuropsychopharmacol 2002; 12: 483-487
71. Schwartz UR, Walter U, Eigenthaler M: Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001; 62: 1153-1161
72. Butler J, O'Halloran A, Leonard BE: The Galway Study of Panic Disorder. II: Changes in some peripheral markers of noradrenergic and serotonergic function in DSM III-R panic disorder. J Affect Disord 1992; 26: 89-99
73. Zafar MU, Paz-Yepes M, Shimbo D, Vilahur G, Burg MM, Chaplin W, Fuster V, Davidson KW, Badimon JJ: Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J 2010; 31: 1573-1582
74. Seldenrijk A, Vogelzangs N, van Hout HP, van Marwijk HW, Diamant M, Penninx BW: Depressive and anxiety disorders and risk of subclinical atherosclerosis. Findings from the Netherlands Study of Depression and Anxiety (NESDA). J Psychosom Res 2010; 69: 203-210.